What is Lou Gehrig’s disease?
The Amyotrophic Lateral Sclerosis (ALS), also called Lou Gehrig’s disease, kills motor neurons to weaken muscles. Muscular dystrophy progresses gradually in the four limbs and sometimes, it paralyzes respiratory muscle in the end to lead to death.
How is Lou Gehrig’s disease treated?
The medicine called Rilutek was introduced in the 1990s and has been utilized since then. Rilutek is used with the hope to extend 3 months of life if administered for 2 years. However, many evaluate the medicine brings only less than satisfactory effect on living quality improvement such as muscular recovery. In this situation, a recently-developed cell medicine (Neuronata R Injection) attracts increasing interest as it helps alleviate the disease if utilized in parallel.
What is the medicine, Neuronata R Injection?
Neuronata R Injection was developed as the world’s first stem cell medicine for Lou Gehrig’s disease. Its efficacy to slow or stop the disease progress has been proven. The principle of its mechanism is to utilize nerve protection and anti-inflammation-mediated immuneregulation to help reduce motor neuron destruction and neural inflammatory reaction.
About Myongji Lou Gehrig Center
• Injecting the world’s first stem cell medicine for Lou Gehrig’s disease ‘Neuronata-R inj.’
• Injecting by separating and culturing the patient’s own stem cells
• Prolonging the survival of motor neurons that are killed
• A medicine approved by KFDA official item authorization
• 1:1 customized rehabilitation treatment by patient status during the admission period
• Preventing muscle stiffness and maintaining daily life ability
• General rehabilitation, respiratory rehabilitation, swallowing rehabilitation, daily life movement rehabilitation etc.
• A patient-customized nutrition assessment and menu composition, recipe management of a professional dietitian
• Providing nutrition concentrates, supplements, drinks for maintaining weight
• Customized diets including high quality protein, moisture, fiber, antioxidant vitamins etc.
| Treatment schedule (subject to change according to a patient’s own status) | |
|---|---|
| 1st hospitalization (7 days) | bone marrow harvest, general chemical test, immunology test, diagonal blood test, swallowing function test, respiratory function test, education on rehabilitation therapy |
| Re-hospitalization in 30 days after the 1st hospitalization | |
| 2nd hospitalization (31 days) | 1st injection, basic blood test, swallowing function test, respiratory function test, rehabilitation therapy, dietary prescription, side effect monitoring |